| Literature DB >> 24951050 |
Jörg A Lisson1, Catharina Weyrich.
Abstract
OBJECTIVES: Primary surgery in patients with complete unilateral and bilateral cleft lip and palate restricts transverse and sagittal maxillary growth. Additional surgical maxillary advancement might become necessary after completion of growth. The aim of this study was to determine the extent of maxillary deficiency at an early stage during the transitory dentition, and to identify factors that might indicate the need for a later maxillary advancement.Entities:
Mesh:
Year: 2014 PMID: 24951050 PMCID: PMC4118318 DOI: 10.1186/1746-160X-10-26
Source DB: PubMed Journal: Head Face Med ISSN: 1746-160X Impact factor: 2.151
Procedures for surgical and orthodontic treatment at Saarland Medical School, Homburg, Germany
| 0 - 12 months | Presurgical orthopedics |
| 6 months | Lip closure after Veau-Manchester, if possible along with hard palate closure after Pichler |
| 10-12 months | Soft palate closure after Veau with push-back procedures after Kriens |
| Primary and transitory dentition | Orthodontic treatment according to individual needs (e.g. frontal or lateral cross bite) |
| Before eruption of the permanent canine | Bone grafting |
| Secondary dentition | Orthodontic treatment (fixed appliances) |
| 16 years or after | Cosmetic corrections of nose and lip, |
| LeFort-I-Osteotomy |
Changes of cast analysis
| | Δ T1-T2 | 0.11 | 2.43 | 0.769 | n.s. |
| Overjet [mm] | Δ T2-T3 | −0.95 | 1.91 | 0.010 | * |
| | Δ T1-T3 | −0.85 | 2.26 | 0.040 | * |
| | Δ T1-T2 | −0.60 | 2.18 | 0.096 | n.s. |
| Overbite [mm] | Δ T2-T3 | −0.19 | 1.72 | 0.553 | n.s. |
| | Δ T1-T3 | −0.83 | 2.64 | 0.095 | n.s. |
| | Δ T1-T2 | 1.069 | 3.84 | 0.910 | n.s. |
| Anterior arch width [mm] | Δ T2-T3 | 0.276 | 2.94 | 0.611 | n.s. |
| | Δ T1-T3 | 1.321 | 3.71 | 0.042 | * |
| | Δ T1-T2 | 0.687 | 4.37 | 0.333 | n.s. |
| Posterior arch width [mm] | Δ T2-T3 | 0.033 | 2.56 | 0.084 | n.s. |
| Δ T1-T3 | 0.732 | 3.94 | 0.310 | n.s. |
(T1: age 10 years; T2 age 15 years; T3: age 18 years; n.s.: not significant; *: significant (p < 0.05).
Changes of cephalometric analysis
| | −2.57 | 3.40 | 0.000 | *** | |
| SNA [°] | Δ T2-T3 | −0.53 | 3.54 | 0.490 | n.s. |
| | Δ T1-T3 | −2.76 | 3.98 | 0.003 | ** |
| | Δ T1-T2 | 0.91 | 2.60 | 0.034 | * |
| SNB [°] | Δ T2-T3 | 0.95 | 1.93 | 0.030 | * |
| | Δ T1-T3 | 2.18 | 2.85 | 0.001 | ** |
| | Δ T1-T2 | −3.49 | 2.46 | 0.000 | *** |
| ANB [°] | Δ T2-T3 | −1.39 | 3.08 | 0.046 | * |
| | Δ T1-T3 | −4.85 | 3.29 | 0.000 | *** |
| | Δ T1-T2 | −3.48 | 3.85 | 0.000 | *** |
| Wits [mm] | Δ T2-T3 | −1.05 | 3.24 | 0.162 | n.s. |
| | Δ T1-T3 | −4.89 | 3.67 | 0.000 | *** |
| | Δ T1-T2 | −0.17 | 3.37 | 0.745 | n.s. |
| NL/NSL [°] | Δ T2-T3 | −0.55 | 3.18 | 0.424 | n.s. |
| | Δ T1-T3 | −0.74 | 4.43 | 0.430 | n.s. |
| | Δ T1-T2 | −0.40 | 3.34 | 0.457 | n.s. |
| ML/NSL [°] | Δ T2-T3 | −1.01 | 2.22 | 0.050 | n.s. |
| | Δ T1-T3 | −2.03 | 3.70 | 0.018 | * |
| | Δ T1-T2 | −0.47 | 4.12 | 0.480 | n.s. |
| ML/NL [°] | Δ T2-T3 | −0.29 | 3.53 | 0.706 | n.s. |
| | Δ T1-T3 | −0.81 | 4.44 | 0.103 | n.s. |
| | Δ T1-T2 | 10.56 | 9.99 | 0.000 | *** |
| Ui/NL [°] | Δ T2-T3 | 2.26 | 6.77 | 0.131 | n.s. |
| Δ T1-T3 | 11.41 | 11.20 | 0.000 | *** |
(T1: age 10 years; T2 age 15 years; T3: age 18 years; n.s.: not significant; *: significant (p < 0.05); **: highly significant (p < 0.01); ***: most highly significant (p < 0.001)).
Pearson-Correlation
| SNA-Wits T1 | 0.447 | 0.010 | * |
| SNA-Wits T2 | 0.619 | 0.000 | *** |
| SNA-Wits T3 | 0.598 | 0.003 | ** |
| SNA-OK44 T1 | 0.108 | 0.509 | n.s. |
| SNA-OK44 T2 | 0.336 | 0.039 | * |
| SNA-OK44 T3 | 0.500 | 0.025 | * |
| SNA-OK66 T1 | −0.040 | 0.809 | n.s. |
| SNA-OK66 T2 | 0.276 | 0.093 | n.s. |
| SNA-OK66 T3 | −0.024 | 0.920 | n.s. |
| SNA-UI/NL T1 | −0.279 | 0.081 | n.s. |
| SNA-UI/NL T2 | −0.305 | 0.059 | n.s. |
| SNA-UI/NL T3 | −0.165 | 0.451 | n.s. |
| SNA-NL/NSL T1 | −0.599 | 0.000 | *** |
| SNA-NL/NSL T2 | −0.663 | 0.000 | *** |
| SNA-NL/NSL T3 | −0.481 | 0.020 | * |
(OK44: anterior arch width; OK66: posterior arch width; (T1: age 10 years; T2 age 15 years; T3: age 18 years; n.s.: not significant; *: significant (p < 0.05); **: highly significant (p < 0.01); ***: most highly significant (p < 0.001)).
Chi-Square-Test according to Pearson
| Number of operations – Maxillary deficiency | 4.649 | 0.098 | n.s. |
| Gender – Maxillary deficiency | 0.101 | 0.751 | n.s. |
| Type of cleft – Maxillary deficiency | 0.482 | 0.786 | n.s. |
(n.s.: not significant).
Number of patients (absolute and percentage) with maxillary deficiency at T1, T2 and T3 and patients with LeFort-I-Osteotomy after completion of growth
| Patients with maxillary deficiency (T1) | 1/40 | 2.50 |
| Patients with maxillary deficiency (T2) | 5/38 | 13.20 |
| Patients with maxillary deficiency (T3) | 11/40 | 27.50 |
| Patients with LeFort-I-Osteotomy | 7/40 | 17.50 |